NewLink Genetics Corp (NASDAQ:NLNK)

52.26
Delayed Data
As of Mar 27
 +3.33 / +6.81%
Today’s Change
17.32
Today|||52-Week Range
57.47
+31.47%
Year-to-Date

Today’s Trading

Previous close48.93
Today’s open49.81
Day’s range49.52 - 52.97
Volume645,945
Average volume (3 months)511,231
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio15.8
Price/Sales6.41
Price/Book6.72

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+1.26+3.83%
LGNDLigand Pharmaceutica...+2.65+3.77%
USNAUSANA Health Science...+4.02+3.74%
CMRXChimerix Inc+0.50+1.37%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account